4.3 Review

Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review

期刊

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
卷 73, 期 11-12, 页码 2249-2271

出版社

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/01635581.2020.1856895

关键词

-

向作者/读者索取更多资源

Bladder cancer is the 9th most prevalent cancer worldwide, with a protracted treatment course and significant patient expense. Current first-line treatments for non-muscle invasive bladder cancer have high rates of tumor recurrence and progression, highlighting the need for new and improved strategies. Natural phytochemicals are being investigated for their potential therapeutic effects on bladder cancer, targeting molecular signaling pathways involved in its pathogenesis.
Bladder cancer is the 9(th) most prevalent cancer worldwide and carries a protracted treatment course with significant patient expense, morbidity, and mortality. Over 95% of bladder cancers arise from the urothelium and invade into the underlying muscle layer before metastasizing. Trans-urethral resection and BCG therapy is the current first-line treatment for non-muscle invasive bladder cancer but carries a high rate of tumor recurrence and progression. The poor outcomes associated with advanced disease indicate the urgent need for new and improved treatment strategies. There is increasing investigation into the molecular signaling pathways involved in bladder cancer pathogenesis with the goal of uncovering potential therapeutic targets. This article reviews the major signaling pathways implicated in bladder cancer, including PI3K/AKT/mTOR, Ras/Raf/MEK/MAPK, NF-kappa B, Wnt/beta-catenin, Notch, Hedgehog, Hippo, JAK/STAT, and TGF-beta as well as major cellular receptors central to cancer pathophysiology, including EGFR, Her2, FGFR, and VEGF. We also discuss various naturally occurring phytochemicals that show evidence of targeting these molecular pathways including curcumin, resveratrol, green tea polyphenols, sulforaphane, erucin, genistein, genipin, baicalein, quercetin, isoquercitin, vitamin E, parthenolide, dioscin, triptolide, kaempferol, pterostilbene, isoliquiritigenin, and escin. This review highlights the potential use of these compounds in treatment of bladder cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据